We initially observed high levels of CD147 expression in multiple breast cancer cell lines compared with normal breast epithelial cells, including BT549, MDA-MB-231 and MCF-7, with differential expression patterns among them, indicating its potential as a promising therapeutic target for breast cancer treatment. Here, BSG is linked to breast carcinoma.